Rohit Chopra, who led the Consumer Financial Protection Bureau, was known for his aggressive enforcement and expansion of consumer protection laws. By Stacy Cowley The director of the Consumer ...

(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for ... after the company spun off its consumer health unit in 2023.

J&J has offered to buy each share of Intra-Cellular for $132, representing a 39% premium to the stock's closing price on Friday. Shares of Intra-Cellular rose 34% to $128 in afternoon trading ...

Johnson & Johnson will acquire Intra-Cellular Therapies for $132 per share in a deal that values the company at $14.6 billion. The acquisition includes FDA-approved CAPLYTA for schizophrenia and ...

China's CPI rose 0.2% in 2024 Factory-gate prices deflationary for 27 months Stimulus impact seen as short-lived BEIJING, Jan 9 (Reuters) - China's consumer prices barely rose in 2024 while ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

While the role of dopamine in these reward-related processes is well-established, the cellular and neural circuit-level mechanisms underpinning its involvement in these processes is not yet fully ...

Scotiabank analyst Andres Coello maintained a Buy rating on Millicom International Cellular SA (TIGO – Research Report) today and set a price target of $37.30. The company’s shares closed ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...

Two new “pioneering” open-access scale-up facilities focused on advancing cellular agriculture are at the centre of a €12.5m investment grant from the Dutch National Growth Fund for Cellular ...

Intra-Cellular Therapies (ITCI) shares soared 14.9% in the last trading session to close at $94.87. The move was backed by solid volume with far more shares changing hands than in a normal session.

Consumer spending will play a large role in the economy in 2025, as it always does. However, the impact has often been overstated. Nonetheless, the strong footing of households—in the aggregate ...